• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

Femtech Investment Round-up (September 2023)

By Femtech Insider Investment Round-ups, News October 2, 2023
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Fertility, News, Pregnancy February 13, 2023
Wingwomen Pivots from Peer Support to Coaching Platform for Women with Preexisting Conditions Trying to Conceive
Endometriosis, Menstrual Health, News, Pelvic Health, Reproductive Health May 15, 2024
TiumBio Shares Positive Phase 2a Trial Results for Merigolix in Endometriosis Treatment Following $12M Funding Round
Recent Posts
  • PCOS Has Been Renamed to PMOS to Reflect Multisystem Disease
  • Mother Ventures Closes $10M Debut Fund Built Around the Mom-as-Consumer Market
  • Australia’s Baymatob Receives Government Funding to Advance Maternal Complication Early Warning System
  • Four New Funds Women’s Health Founders Should Know About
  • Artera Receives FDA Clearance for AI-Powered Breast Cancer Risk Stratification Tool

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.